Role of Gut Mycobiome in Lung Cancer Immunotherapy: Mechanisms, Challenges and Translational Prospects
Authors:
Open Access
- 20 March 2026
- journal article
- review article
- Vol. 29 (3) , 200-207-207
Abstract
Role of Gut Mycobiome in Lung Cancer Immunotherapy: Mechanisms, Challenges and Translational ProspectsKeywords
This publication has 42 references indexed in Scilit:
- Fungal Immunomodulatory Protein from Nectria haematococca Suppresses Growth of Human Lung Adenocarcinoma by Inhibiting the PI3K/Akt PathwayInternational Journal of Molecular Sciences, 2018
- Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer DevelopmentToxins, 2018
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsScience, 2018
- Extraction and Isolation of β‐Glucan from Grain Sources—A ReviewJournal of Food Science, 2017
- Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex FormationPLOS ONE, 2016
- Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in CancerThe Journal of Immunology, 2016
- Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like PhenotypeThe Journal of Immunology, 2015
- Inonotus obliquus-derived polysaccharide inhibits the migration and invasion of human non-small cell lung carcinoma cells via suppression of MMP-2 and MMP-9International Journal of Oncology, 2014
- Bacterial-Fungal Interactions: Hyphens between Agricultural, Clinical, Environmental, and Food MicrobiologistsMicrobiology and Molecular Biology Reviews, 2011
- Immunity to fungal infectionsNature Reviews Immunology, 2011